![](https://danskbiotek.dk/wp-content/uploads/2022/11/Virogates-news-300x191.png)
Development of suPAR tests for commercial use in the US is a post-authorisation reqirement in new EUA of Kineret for COVID-19 10 November 2022
ViroGates announces the emergency use authorisation of Kineret treatment for COVID-19 related pneumonia... Read more